• AG-120 (Ivosidenib): Benchmarks for Mutant IDH1 Inhibition i

  2026-05-06

  AG-120 (Ivosidenib) is a selective, orally bioavailable inhibitor of mutant IDH1, validated for reducing 2-hydroxyglutarate and restoring myeloid differentiation in AML. Comprehensive evidence demonstrates its molecular selectivity, clinical efficacy, and key limitations in therapy.

• Microbiota–Tryptophan–AhR Axis Drives ISC Differentiation in

  2026-05-05

  Li et al. reveal how Huangqin decoction (HQD) restores intestinal barrier integrity in ulcerative colitis by modulating the gut microbiota, enhancing tryptophan-derived AhR ligands, and triggering aryl hydrocarbon receptor (AhR)-mediated intestinal stem cell (ISC) differentiation. This study establishes a mechanistic link between microbiota-driven metabolism, AhR signaling, and mucosal repair, informing new strategies in environmental toxicology and regenerative medicine.

• Adiponectin Mitigates Neuroinflammation via TLR4/NF-κB in PN

  2026-05-05

  This study demonstrates that adiponectin (APN) significantly reduces splenectomy-induced cognitive deficits in aged rats by suppressing neuroinflammation and oxidative stress through the TLR4/MyD88/NF-κB signaling pathway. The findings highlight a mechanistically defined therapeutic target for perioperative neurocognitive disorder and provide direction for future peptide-based interventions.

• Balsalazide Disodium Dihydrate: Integrative Pharmacology for

  2026-05-04

  Explore the multifaceted roles of Balsalazide disodium in inflammation research, from pharmacological innovation to practical assay design. This article uniquely unpacks protocol decisions, translational impact, and the pivotal findings that set sodium (E)-5-((4-((2-carboxylatoethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoate dihydrate apart.

• CD44-Driven Metabolic Rewiring in IDH-Mutant AML: New Vulner

  2026-05-04

  This study uncovers how CD44 activation supports metabolic adaptation in IDH-mutant acute myeloid leukemia (AML), enabling sustained oncometabolite (R)-2-hydroxyglutarate production. By mechanistically linking CD44 to pentose phosphate pathway activation and therapeutic resistance, the work reveals testable vulnerabilities for combinatorial inhibition strategies.

• ECL Western Blotting Substrate: Technical Guide & Workflow U

  2026-05-03

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent designed for sensitive protein identification in Western blot assays. It is intended for chemiluminescent detection in molecular biology, cancer biology, and signal transduction research, but is not suitable for fluorescent or radioisotopic assays. Researchers should use this product for applications requiring high signal-to-noise and reprobing capability, and avoid it where alternative detection modalities are needed.

• Puerarin Activates Nitric Oxide Pathway for Osteogenic Diffe

  2026-05-02

  The referenced study demonstrates that puerarin enhances osteogenic differentiation of rat dental follicle cells (rDFCs) via activation of the nitric oxide pathway. This mechanistic insight, established through rigorous use of NOS inhibition with L-NMMA, offers new avenues for periodontal regeneration research and underscores the value of precise nitric oxide pathway modulation.

• Troglitazone (A3893): Reliable PPARγ Agonist for Assay Preci

  2026-05-02

  This article delivers scenario-driven, evidence-based guidance for researchers deploying Troglitazone (SKU A3893) in cell viability, proliferation, and cytotoxicity assays. It addresses workflow reproducibility, assay compatibility, and product reliability, providing actionable recommendations and protocol parameters rooted in current literature and product specifications.

• LG 101506 (RXR Modulator): Applied Workflows in RXR Signalin

  2026-05-01

  LG 101506, a high-purity RXR modulator from APExBIO, empowers researchers to precisely dissect RXR-driven mechanisms in cancer and metabolic biology. This article translates recent breakthroughs in immune checkpoint regulation into actionable workflows and troubleshooting strategies for maximizing the impact of LG 101506 in advanced RXR signaling studies.

• Cy5 TSA Fluorescence System Kit: Amplifying Detection Precis

  2026-04-30

  Unlock ultra-sensitive detection in IHC, ICC, and FISH with the Cy5 TSA Fluorescence System Kit, leveraging horseradish peroxidase catalyzed tyramide deposition for up to 100-fold signal amplification. APExBIO's solution is tailored for researchers targeting low-abundance molecules, enabling breakthrough discoveries in complex tissue contexts.

• Y-27632 Dihydrochloride: ROCK Inhibition and Adaptive Cancer

  2026-04-30

  Explore how Y-27632 dihydrochloride enables precise ROCK inhibition in advanced cancer research, with a unique focus on metabolic adaptation and assay design. Gain evidence-based insights that go beyond cytoskeletal modulation.

• Vemurafenib (PLX4032) in Melanoma: Protocols, Resistance, an

  2026-04-29

  Vemurafenib (PLX4032) empowers researchers to dissect BRAF-mutant melanoma biology, unravel resistance mechanisms, and optimize antitumor workflows with quantitative rigor. This guide translates recent multi-omics insights into actionable protocols and troubleshooting strategies for maximizing experimental clarity, reproducibility, and translational relevance.

• Small Molecule Antagonists Targeting Shh-Heparin Binding in

  2026-04-29

  Lamson et al. identify and characterize novel small molecule antagonists that block the interaction between Sonic hedgehog and heparin, disrupting Hedgehog pathway signaling at the ligand-receptor interface. Their high-throughput approach provides new chemical tools for dissecting pathway regulation, with implications for developmental biology, disease modeling, and targeted screening.

• Dihydrotestosterone (DHT): Advanced Mechanisms in Androgen R

  2026-04-28

  Explore the advanced mechanisms of Dihydrotestosterone (DHT) in androgen receptor and EGFR signaling, and discover how cutting-edge findings reshape assay design and therapeutic research. This article offers a deep-dive into DHT's multifaceted applications, grounded in recent scientific advances.

• Hypoxia-Induced Choroid Plexus Disruption and Cognitive Defi

  2026-04-28

  This study reveals that high-altitude hypoxic exposure impairs cognitive function in mice by disrupting the choroid plexus barrier, mediated through AMPK pathway dysregulation and M1 macrophage polarization. The work provides mechanistic insight into CNS vulnerability under hypoxic stress and highlights potential intervention targets for hypoxia-related cognitive disorders.

449 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page